151 related articles for article (PubMed ID: 12792926)
1. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
Sun T; Pashaei S; Jaffrey I; Ryder J
Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
[TBL] [Abstract][Full Text] [Related]
2. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
Natkunam Y; Cherry AM; Cornbleet PJ
Arch Pathol Lab Med; 2001 Mar; 125(3):413-8. PubMed ID: 11231495
[TBL] [Abstract][Full Text] [Related]
4. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
[TBL] [Abstract][Full Text] [Related]
5. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
6. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
[TBL] [Abstract][Full Text] [Related]
7. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
9. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
11. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
[TBL] [Abstract][Full Text] [Related]
12. Pediatric acute blastic natural killer cell leukemia.
DuBois SG; Etzell JE; Matthay KK; Robbins E; Banerjee A
Leuk Lymphoma; 2002 Apr; 43(4):901-6. PubMed ID: 12153184
[TBL] [Abstract][Full Text] [Related]
13. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
[TBL] [Abstract][Full Text] [Related]
14. Myeloid/NK cell acute leukemia.
Chen B; Xu X; Ji M; Lin G
Int J Hematol; 2009 Apr; 89(3):365-367. PubMed ID: 19326059
[TBL] [Abstract][Full Text] [Related]
15. Myeloid/natural killer cell precursor acute leukemia with tetraploidy.
Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B
Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859
[TBL] [Abstract][Full Text] [Related]
16. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
Zhang K; Prichard JW; Brown RE
Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
[TBL] [Abstract][Full Text] [Related]
17. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
18. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
Chen VM; McIlroy K; Loui JP; Fay K; Ward C
Pathology; 2003 Aug; 35(4):325-9. PubMed ID: 12959763
[TBL] [Abstract][Full Text] [Related]
19. Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression.
Isobe K; Tamaru JI; Nakamura S; Itami J; Aruga T; Uno T; Yasuda S; Mikata A; Ito H
Pathol Int; 2001 Jan; 51(1):55-9. PubMed ID: 11148466
[TBL] [Abstract][Full Text] [Related]
20. Progress in understanding and managing natural killer-cell malignancies.
Oshimi K
Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
